Information sent to healthcare professionals in November 2009 about the safety of medicines

Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.

A list of letters sent to healthcare professionals in November 2009, to inform of new safety information and advice.

Date issued Product Safety information
6 November 2009 Abraxane (paclitaxel)

Voluntary recall - precautionary action due to particulate matter observed in a number of vials

Letter for pharmacistsPDF file (opens in new window) (102Kb)

Letter for oncologistsPDF file (opens in new window) (39Kb)

7 November 2009 MabThera (rituximab)PDF file (opens in new window) (55Kb) A third case of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis receiving MabThera.
30 November 2009 alli (orlistat)PDF file (opens in new window) (730Kb) Warnings on oxalate nephropathy, interaction with levothyroxine, and interaction with antiepileptic drugs

Page last modified: 12 January 2010